Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-37.85M
↑ 40% above average
Average (8y)
$-63.42M
Historical baseline
Range
High:$-16.12M
Low:$-103.42M
CAGR
+11.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-37.85M | +23.2% |
| 2023 | $-49.29M | +52.3% |
| 2022 | $-103.42M | 0.0% |
| 2021 | $-103.42M | -7.0% |
| 2020 | $-96.62M | -19.4% |
| 2019 | $-80.94M | -40.1% |
| 2018 | $-57.79M | -127.8% |
| 2017 | $-25.36M | -57.3% |
| 2016 | $-16.12M | - |